#opioidusedisorder
Among pregnant and postpartum individuals with #OpioidUseDisorder, longer duration of medications for opioid use disorder was associated with lower 1-year risk of overdose or death after delivery.

ja.ma/3VHFOse
Duration of Medication for Opioid Use Disorder and Postpartum Overdose and Death
This cohort study examines whether longer duration of medications for opioid use disorder dispensed during pregnancy and early post partum is associated with reduced overdose and death through 365 days post partum.
ja.ma
October 10, 2026 at 2:30 PM
Among Medicaid-enrolled youths with #OpioidUseDisorder, only 1 in 6 received medication for opioid use disorder and only 1 in 32 had 180 days or more of medication retention.

ja.ma/3VXzc9e
October 10, 2026 at 2:00 PM
Among patients with #OpioidUseDisorder offered buprenorphine in the emergency department, declination was associated more with concerns about precipitated withdrawal, physical dependence, and housing barriers than with lower treatment readiness. ja.ma/4hKNeCl
October 9, 2026 at 11:00 AM
Patients with #OpioidUseDisorder reported that in-person methadone dosing visits required substantial travel time and cost, while wait times, clinic hours, and transportation barriers further limited treatment access. ja.ma/4hKL3Pb
October 9, 2026 at 10:30 AM
New study: telemedicine bridge clinics improved buprenorphine continuity, cut ED visits 18%, lowered Medicaid spending. Co-authored by CP3's Julie Donohue.

www.sciencedirect.com/science/arti...

#OpioidUseDisorder #Telemedicine #Medicaid
September 30, 2026 at 3:39 PM
Among patients hospitalized with #OpioidUseDisorder in Philadelphia, dexmedetomidine use rose after medetomidine emerged in the illicit fentanyl supply, and nearly all such admissions involved the intensive care unit.

ja.ma/4y1jQy4
September 29, 2026 at 2:00 PM
September 24th is Save A Life Day!! Be a hero and carry naloxone. Reach out to your local prevention team for more details.

#savealifeday #opioidawareness #opioidusedisorder #naloxonesaveslives #narcansaveslives
September 24, 2026 at 7:16 PM
Suboxone is an FDA-approved medication that supports a broader, structured treatment program for opioid addiction.

It’s only available in hospitals and rehab centers.

#OpioidDetox #Rehab #OpioidUseDisorder

Learn More:
https://buenavistarecovery.com/blog/going-to-detox-or-rehab-while-on-suboxone/
September 11, 2026 at 3:05 PM
Among patients receiving #Methadone for #OpioidUseDisorder, take-home dosing after completed induction was associated with lower mortality vs no take-home dosing, with the greatest benefit when started within 5 to 12 weeks or 13 to 24 weeks. ja.ma/4cswSfX
September 9, 2026 at 2:00 PM
August 31, 2026 at 5:11 PM
Federal policy shifts and immigration fears are creating new barriers to opioid treatment outreach in Brooklyn – and frontline staff are finding ways through.

#MAT #HarmReduction #OpioidUseDisorder
Medication-Assisted Treatment on the Ground: How Federal Policy Shifts Are Reshaping Outreach in Brooklyn
Learn how person-centered, trauma-informed MAT programs overcome stigma and policy barriers to expand opioid treatment and recovery support.
behavioralhealthnews.org
August 27, 2026 at 5:30 PM
August 11, 2026 at 6:33 AM
Connecticut's Department of Public Health is stepping up efforts to save lives by targeting high-risk populations with vital overdose prevention strategies.

Learn more here

#CT #OpioidUseDisorder #PublicHealth #CitizenPortal
DPH says it is focusing outreach on people leaving jail, syringe services and EMS leave-behind naloxone protocols
A Department of Public Health official said DPH is prioritizing outreach to people recently released from correctional facilities, partnering with syringe services programs for naloxone training, working with Planned Parenthood on screening, and promoting EMS naloxone leave-behind protocols in Trumbull and East Lyme.
citizenportal.ai
August 7, 2026 at 1:53 AM
Registration is open for the PCSS-MOUD Exchange, a free four-session course for interprofessional teams implementing medications for opioid use disorder.

First session August 5, 2026, at 3:00 PM ET.

Register at pcssnow.org.

#MOUD #OpioidUseDisorder #SubstanceUseCare
August 4, 2026 at 7:01 PM
Adjunctive #psychosocial interventions did not improve #opioid #abstinence or retention during the first year of buprenorphine treatment for #OpioidUseDisorder in federally qualified health centers.

ja.ma/3Tt21Jk
July 11, 2026 at 1:00 PM
From @ofidjournal.bsky.social 🦠🫀

Patients with injection drug use-related #InfectiveEndocarditis who receive medications for #OpioidUseDisorder tend to be more likely to complete #antibiotic treatment and are at lower risk of mortality at 30 days.
MOUD Decreases Short-Term Mortality Risk After IDU-Related Infective Endocarditis
Initiating MOUD is associated with higher antibiotic completion and lower 30-day mortality in IDU-related IE.
www.infectiousdiseaseadvisor.com
June 29, 2026 at 5:13 PM
Francesca LoFaro, in Dr. Konova’s lab, explores addictive behaviors throughout women’s menstrual cycles. Her project studies how changing estradiol and progesterone levels shape dopamine signaling, reward sensitivity, and opioid reuse risk for women taking #OpioidUseDisorder treatment medications.
June 24, 2026 at 8:12 PM
Congratulations to Jirka Taylor, MPhil, MA, on successfully defending his PhD dissertation, “Examining linkage to care after non-fatal opioid overdoses: A mixed-methods study.”

#dissertation #opioidusedisorder #ems #emergencydepartment
June 23, 2026 at 2:25 PM
Higher daily short-acting opioid doses for withdrawal were associated with reduced risk of early patient-directed discharge in hospitalized patients with #OpioidUseDisorder.

ja.ma/4fS6gHK
June 20, 2026 at 3:30 PM
Insurance, reimbursement, and regulatory structures shaped adoption of low-barrier #BuprenorphineTreatment, often limiting timely care for #OpioidUseDisorder, according to clinician perspectives.

ja.ma/4uRdsYh
June 20, 2026 at 3:00 PM